Here's a look at some of the top legal news stories for medical device companies this week: Olympus to pay $92m to settle accounting fraud case; Insurer wants out of $28m Biotronik legal loss; Medtronic to pay feds $4m to settle product labeling case
Here's a look at some of the top Wall Street stories for medical device companies this week: Johnson & Johnson taps Google for robot-assisted surgery program; Olympus to pay $92m to settle accounting fraud case; Philips sells stake in lighting biz for $3B; ReWalk Robotics plans Q2 launch in India
Olympus says it agreed to pay $92 million to settle a pair of civil lawsuits brought over the 2001 accounting scandal that nearly brought the company down.
Olympus issues an urgent safety advisory on cleaning the endoscopes implicated in lethal 'superbug' outbreaks across the country.
Olympus faces another lawsuit over a 'superbug' infection allegedly caused by 1 of its endoscopes.
A patient infected with a drug-resistant 'superbug' at a Los Angeles hospital sues Olympus, the maker of the endoscope that allegedly caused the infection.
(Reuters) — A 76-year-old man infected with a drug-resistant "superbug" at a Los Angeles hospital has sued the manufacturer of a medical device that allegedly caused the illness in the 5th lawsuit related to the bacterial outbreak at the facility, his attorney said yesterday.
The FDA's gastroenterology & urology devices advisory panel is slated to meet in May to review the recent, deadly outbreak of hospital-acquired infections from endoscopy procedures.
(Reuters) — The FDA said an advisory panel is slated to discuss the transmission of "superbug" infections through endoscopy procedures in U.S. hospitals.